Alamar Biosciences, Inc. (California) (ALMR)
23.62
-0.62
(-2.56%)
USD |
NASDAQ |
Oct 13, 14:59
Alamar Biosciences Total Return Level : 24.24 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 24.24 |
| October 09, 2026 | 25.27 |
| October 08, 2026 | 25.91 |
| October 07, 2026 | 27.77 |
| October 06, 2026 | 32.26 |
| October 05, 2026 | 38.13 |
| October 02, 2026 | 34.36 |
| October 01, 2026 | 32.46 |
| September 30, 2026 | 34.07 |
| September 29, 2026 | 32.65 |
| September 28, 2026 | 32.61 |
| September 25, 2026 | 32.80 |
| September 24, 2026 | 33.20 |
| September 23, 2026 | 32.14 |
| September 22, 2026 | 33.22 |
| September 21, 2026 | 35.05 |
| September 18, 2026 | 34.85 |
| September 17, 2026 | 32.01 |
| September 16, 2026 | 29.38 |
| September 15, 2026 | 28.75 |
| September 14, 2026 | 27.99 |
| September 11, 2026 | 27.89 |
| September 10, 2026 | 27.77 |
| September 09, 2026 | 28.96 |
| September 08, 2026 | 29.95 |
| Date | Value |
|---|---|
| September 04, 2026 | 30.80 |
| September 03, 2026 | 30.57 |
| September 02, 2026 | 30.49 |
| September 01, 2026 | 29.36 |
| August 31, 2026 | 30.54 |
| August 28, 2026 | 30.71 |
| August 27, 2026 | 33.00 |
| August 26, 2026 | 34.08 |
| August 25, 2026 | 33.02 |
| August 24, 2026 | 32.70 |
| August 21, 2026 | 34.24 |
| August 20, 2026 | 34.64 |
| August 19, 2026 | 35.54 |
| August 18, 2026 | 32.96 |
| August 17, 2026 | 32.13 |
| August 14, 2026 | 33.16 |
| August 13, 2026 | 32.92 |
| August 12, 2026 | 33.12 |
| August 11, 2026 | 36.57 |
| August 10, 2026 | 27.99 |
| August 07, 2026 | 28.46 |
| August 06, 2026 | 28.10 |
| August 05, 2026 | 28.35 |
| August 04, 2026 | 27.11 |
| August 03, 2026 | 27.07 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Personalis, Inc. | 15.80 |
| 10X Genomics, Inc. | 75.19 |
| Adaptive Biotechnologies Corp. | 25.57 |
| Champions Oncology, Inc. | 4.953 |
| Medpace Holdings, Inc. | 620.05 |